The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksELTA.L Regulatory News (ELTA)

  • There is currently no data for ELTA

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Form 8.5 (EPT/RI) - Electra Private Equity plc

9 Jul 2018 10:28

RNS Number : 0108U
Morgan Stanley & Co. Int'l plc
09 July 2018
 

 

 FORM 8.5 (EPT/RI)

PUBLIC DEALING DISCLOSURE BY AN EXEMPT PRINCIPAL TRADER WITH RECOGNISED INTERMEDIARY STATUS DEALING IN A CLIENT-SERVING CAPACITY

Rule 8.5 of the Takeover Code (the "Code")

 

1. KEY INFORMATION

 

(a) Name of exempt principal trader:

Morgan Stanley & Co. International plc

(b) Name of offeror/offeree in relation to whose relevant securities this form relates:

Use a separate form for each offeror/offeree

Electra Private Equity plc

(c) Name of the party to the offer with which exempt principal trader is connected:

 

Electra Private Equity plc

(d) Date dealing undertaken:

06 JULY 2018

(e) Has the EPT previously disclosed, or is it today disclosing, under the Code in respect of any other party to this offer?

No

 

2. DEALINGS BY THE EXEMPT PRINCIPAL TRADER

 

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(b), copy table 2(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

 

 The currency of all prices and other monetary amounts should be stated.

 

 

(a) Purchases and sales

 

 Class of relevant security

 Purchases/sales

 Total number of securities

 Highest price per unit paid/received

 Lowest price per unit paid/received

 25p ordinary

 PURCHASES

 5

 9.1000 GBP

 9.1000 GBP

 25p ordinary

 SALES

 5

 9.1000 GBP

 9.1000 GBP

 

 

(b) Cash-settled derivative transactions

 

 Class of relevant security

 Product description

e.g. CFD

 Nature of dealing

e.g. opening/closing a long/short position, increasing/reducing a long/short position

 Number of reference securities

 Price per unit

 25p ordinary

 CFD

 LONG

 3,504

 9.0000 GBP

 25p ordinary

 CFD

 SHORT

 3,506

 9.0000 GBP

 

 

(c) Stock-settled derivative transactions (including options)

 

(i) Writing, selling, purchasing or varying

 

 Class of relevant security

 Product description e.g. call option

 Writing, purchasing, selling, varying etc.

 Number of securities to which option relates

 Exercise price per unit

 Type e.g. American, European etc.

 Expiry date

 Option money paid/ received per unit

 N/A

 N/A

 N/A

 N/A

 N/A

 N/A

 N/A

 N/A

 

(ii) Exercise

 

 Class of relevant security

 Product description e.g. call option

 Number of securities

 Exercise price per unit

 N/A

 N/A

 N/A

 N/A

 

(d) Other dealings (including subscribing for new securities)

 

 Class of relevant security

 Nature of dealing e.g. subscription, conversion

 Details

 Price per unit (if applicable)

 N/A

 N/A

 N/A

 N/A

 

The currency of all prices and other monetary amounts should be stated.

 

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(b), copy table 2(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

 

 

 

3. OTHER INFORMATION

 

(a) Indemnity and other dealing arrangements

 

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the exempt principal trader making the disclosure and any party to the offer or any person acting in concert with a party to the offer:

If there are no such agreements, arrangements or understandings, state "none"

 

None

 

 

 

 

(b) Agreements, arrangements or understandings relating to options or derivatives

 

 

Details of any agreement, arrangement or understanding, formal or informal, between the exempt principal trader making the disclosure and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state "none"

 

None

 

 

 

 

Date of disclosure:

09 JULY 2018

Contact name:

Craig Horsley

Telephone number:

+44(141) 245 7736

 

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service and must also be emailed to the Takeover Panel at monitoring@disclosure.org.uk. The Panel's Market Surveillance Unit is available for consultation in relation to the Code's dealing disclosure requirements on +44 (0)20 7638 0129.

 

The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
FERGCGDRLDGBGIC
Date   Source Headline
16th Nov 20169:46 amRNSHolding(s) in Company
8th Nov 20167:00 amRNSPROPOSED RETURN OF UP TO £200M TO SHAREHOLDERS
14th Oct 20167:00 amRNSResult of Strategic Review - Phase I
7th Oct 20167:05 amRNSElectra Partners announces the sale of Vidal Group
4th Oct 20167:10 amRNSPartial realisation of Premier Asset Management
23rd Sep 201611:37 amRNSElectra Partners completes the sale of Elian
16th Sep 20167:08 amRNSElectra Private Equity Hollywood IPO Release
1st Sep 20165:34 pmRNSHolding(s) in Company
16th Aug 20164:14 pmRNSHolding(s) in Company
3rd Aug 20163:55 pmRNSDirector/PDMR Shareholding
3rd Aug 20163:53 pmRNSDirector/PDMR Shareholding
27th Jul 20165:23 pmRNSDirector/PDMR Shareholding
22nd Jul 20167:00 amRNSAppointment of Chief Financial Officer
19th Jul 20163:43 pmRNSDirector/PDMR Shareholding
19th Jul 201611:37 amRNSDirector/PDMR Shareholding
1st Jul 20167:00 amRNSPartial realisation of Allflex
28th Jun 20164:45 pmRNSDirector Declaration
20th Jun 20167:00 amRNSDirectorate Change
17th Jun 20164:21 pmRNSHalf-year Report
14th Jun 20167:00 amRNSCancellation of Revolving Credit Facility
6th Jun 20169:31 amRNSDirector/PDMR Shareholding
6th Jun 20167:21 amRNSElectra Partners agrees sale of Elian
2nd Jun 20163:56 pmRNSDirectorate Change
2nd Jun 20169:30 amRNSAdditional Information re Board Appointments
27th May 20169:46 amRNSDirector/PDMR Shareholding
26th May 20167:00 amRNSInterim Update on Strategic Review
4th May 20167:00 amRNSHalf-year Report
19th Apr 20167:00 amRNSDirectorate Change
4th Apr 201612:06 pmRNSDirector/PDMR Shareholding
16th Mar 20169:48 amRNSDirector/PDMR Shareholding
1st Mar 20165:47 pmRNSDirector/PDMR Shareholding
25th Feb 20166:30 pmRNSDisclosure of home member state
25th Feb 20167:00 amRNSChange of broker
10th Feb 201612:13 pmRNSDirector/PDMR Shareholding
4th Feb 20169:29 amRNSDirector/PDMR Shareholding
4th Feb 20167:00 amRNSElectra announces the sale of Daler-Rowney
29th Jan 201611:11 amRNSDirector/PDMR Shareholding
28th Jan 20167:00 amRNSQuarterly Update Report
26th Jan 20164:53 pmRNSHolding(s) in Company
26th Jan 201612:20 pmRNSSpecial Resolution passed at AGM - 25 January 2016
26th Jan 20167:00 amRNSResult of AGM
25th Jan 20167:00 amRNSBoard review of investment policy and structure
12th Jan 20161:56 pmRNSDirector/PDMR Shareholding
8th Jan 20162:34 pmRNSHolding(s) in Company
6th Jan 201610:27 amRNSDirector/PDMR Shareholding
4th Jan 201610:15 amRNSTotal Voting Rights
4th Jan 20169:57 amRNSHolding(s) in Company
31st Dec 201510:17 amRNSBlocklisting Interim Review
30th Dec 20153:40 pmRNSMandatory Conversion of Bonds clarification
30th Dec 201510:20 amRNSMandatory Conversion of Convertible Bonds

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.